IL-21-treated naive CD45RA + CD8 + T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
作者单位:Center for Blood Transfusion, University Medical Center of the Johannes Gutenberg, University Mainz[1]Department of Medicine III, Hematology and Oncology, University Medical Center of the Johannes[2]